HSF1 and Huntington disease: It is believed that decreased levels and activity of HSF1 contribute to neuronal dysfunction and pathogenesis, suggesting HSF1 as a potential therapeutic target for HD intervention (Sittler et al., 2001; Neef et al., 2011).